Corteva (CTVA) Q4 2024 earnings summary

Executive summary

• Achieved record 20% operating EBITDA margin for 2024, with $3.4B operating EBITDA flat year-over-year and $1.7B free cash flow, a 50% conversion rate, despite challenging market conditions.

• Returned $1.5B to shareholders in 2024 via dividends and buybacks; planning $1B in share repurchases for 2025.

• Seed segment saw share gains in key crops and markets, with Enlist E3 soybeans reaching 65% U.S. market penetration; Crop Protection delivered strong Q4 margin expansion, especially in Brazil.

• Full-year 2024 results aligned with expectations, driven by technology demand and disciplined execution.

• FY 2025 guidance targets 10% operating EBITDA growth at midpoint, margin improvement of 100–150 bps, and operating EPS of $2.70–$2.95.

Financial highlights

• Q4 2024 net sales rose 7% year-over-year to $4.0B; organic sales up 13%.

• Q4 operating EBITDA increased 36% to $525M; margin expanded by ~280 bps to 13.2%.

• Full-year 2024 net sales declined 2% to $16.9B; organic sales up 1%.

• Full-year operating EBITDA was $3.4B, flat year-over-year; margin reached a record 20.0%, up 34 bps.

• Free cash flow improved by nearly $500M to $1.7B in 2024, with a 50% EBITDA conversion rate.

Outlook and guidance

• 2025 operating EBITDA expected at $3.6–$3.8B, up 10% at midpoint; margin expected at 21.0–21.5%.

• Operating EPS guidance: $2.70–$2.95, up 10% at midpoint; free cash flow to EBITDA conversion expected at 40–45%.

• 2025 net sales expected between $17.2B and $17.6B, up 3% at midpoint.

• Guidance reflects currency headwinds, mainly from the Brazilian real, Turkish lira, and Canadian dollar, with a $275M EBITDA headwind.

• Key sensitivities include currency fluctuations, corn acreage in North and Latin America, and Crop Protection market pricing.